{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:52:17Z","timestamp":1785873137236,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.neurol.2011.02.035","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T17:24:21Z","timestamp":1303147461000},"page":"600-606","source":"Crossref","is-referenced-by-count":15,"title":["Relation entre les concentrations plasmatiques d\u2019acide valpro\u00efque et la survenue d\u2019une h\u00e9patotoxicit\u00e9"],"prefix":"10.1016","volume":"167","author":[{"given":"H.","family":"Ghozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Sahnoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ben Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Atheymen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hammami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Zeghal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neurol.2011.02.035_bib0005","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1503\/cmaj.061272","article-title":"A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver","volume":"177","author":"Alqahtani","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.neurol.2011.02.035_bib0010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1528-1157.1992.tb02355.x","article-title":"Effect of valproate dose on formation of hepatotoxic metabolites","volume":"33","author":"Anderson","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2011.02.035_bib0015","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1023\/A:1005520523502","article-title":"Chronic liver injury related to use of bentazepam: an unusual instance of benzodiazepine hepatotoxicity","volume":"45","author":"Andrade","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.neurol.2011.02.035_bib0020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.reaurg.2004.03.014","article-title":"Intoxications graves par l\u2019acide valpro\u00efque","volume":"13","author":"B\u00e9dry","year":"2004","journal-title":"Reanimation"},{"issue":"56","key":"10.1016\/j.neurol.2011.02.035_bib0030","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1212\/WNL.56.10.1405","article-title":"Effect of L-carnitine treatment for valproate induced hepatotoxicity","volume":"22","author":"Bohan","year":"2001","journal-title":"Neurology."},{"key":"10.1016\/j.neurol.2011.02.035_bib0035","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0370-4475(80)80035-9","article-title":"Severe vigilance disturbances: a rare complication of sodium valproate treatment","volume":"10","author":"Cenraud","year":"1980","journal-title":"Rev Electroencephalogr Neurophysiol Clin"},{"key":"10.1016\/j.neurol.2011.02.035_bib0040","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/ana.410060616","article-title":"Acute intoxication with sodium valproate","volume":"6","author":"Chadwick","year":"1979","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2011.02.035_bib0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/088307389100600102","article-title":"Valproate, and toxicity","volume":"6","author":"Coulter","year":"1991","journal-title":"J Child Neurol"},{"key":"10.1016\/j.neurol.2011.02.035_bib0050","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1528-1157.1998.tb01315.x","article-title":"L-carnitine supplementation in childhood epilepsy: current perspectives","volume":"39","author":"De Vivo","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2011.02.035_bib0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/00365528209182041","article-title":"Drug-induced liver disease in Denmark. An analysis of 572\u00a0cases of hepatotoxicity reported to the Danish Board of Adverse Reactions to Drugs","volume":"17","author":"Dossing","year":"1982","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.neurol.2011.02.035_bib0060","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1111\/j.1528-1157.1987.tb05768.x","article-title":"Hepatic considerations in the use of antiepileptic drugs","volume":"28Suppl2","author":"Dreifuss","year":"1987","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.neurol.2011.02.035_bib0070","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1528-1157.2003.07202.x","article-title":"Effects of age and polytherapy, risk factors of valproic acid (VPA) hepatotoxicity, on the excretion of thiol conjugates of (E)-2,4-diene VPA in people with epilepsy taking VPA","volume":"44","author":"Gopaul","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2011.02.035_bib0075","unstructured":"Granel B, Gavaret M, Le Baut X, Sautereau N, Rodriguez D, Rossi P, et al. Valproate-induced hyperammonemic encephalopathy. Rev Med Interne 2010 [Epub ahead of print]."},{"key":"10.1016\/j.neurol.2011.02.035_bib0080","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0090-9556(25)08205-4","article-title":"In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analogue 4-pentanoic acid","volume":"21","author":"Kasakun","year":"1993","journal-title":"Drug Metab dispo"},{"key":"10.1016\/j.neurol.2011.02.035_bib0085","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.1840040609","article-title":"The hepatotoxicity of valpro\u00efc acid and its metabolites in rats. I. toxicologic, biochemical and histopathologic studies","volume":"4","author":"Kesterson","year":"1984","journal-title":"Hepathology"},{"key":"10.1016\/j.neurol.2011.02.035_bib0090","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1528-1157.1999.tb00814.x","article-title":"Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults","volume":"40","author":"Koenig","year":"1999","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.neurol.2011.02.035_bib0095","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/j.1528-1167.2006.00846.x","article-title":"Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994\u00a0to 2003","volume":"47","author":"Koenig","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2011.02.035_bib0100","first-page":"448","article-title":"Fatty acid b -oxydation during valproic acid therapy and the r\u00f4le of carnitine","volume":"30","author":"Kossak","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2011.02.035_bib0105","first-page":"365","article-title":"Historique du d\u00e9veloppement du valproate dans les troubles bipolaires","volume":"27","author":"Lemp\u00e9ri\u00e8re","year":"2001","journal-title":"L\u2019enc\u00e9phale"},{"key":"10.1016\/j.neurol.2011.02.035_bib0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/ajem.2001.25272","article-title":"2000\u00a0Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System","volume":"19","author":"Litovitz","year":"2001","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.neurol.2011.02.035_bib0115","first-page":"241","article-title":"Stuporous states during treatment with sodium valproate. Pathogenetic hypotheses","volume":"137","author":"Marescaux","year":"1981","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2011.02.035_bib0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0920-1211(92)90098-E","article-title":"Variability and clinical relevance of the interaction between sodium valproate and carbamazepine in epileptic patients","volume":"11","author":"McKee","year":"1992","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.neurol.2011.02.035_bib0125","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1528-1157.1996.tb00634.x","article-title":"Effect of L-carnitine supplementation on acute valproate intoxication","volume":"37","author":"Murakami","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2011.02.035_bib0130","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1542\/peds.113.S3.1097","article-title":"Liver","volume":"113","author":"Pi\u00f1eiro-Carrero","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.neurol.2011.02.035_bib0205","series-title":"Advances in Epileptology","first-page":"366","article-title":"Acute intoxication during a cpmbined treatment of sodium valproate and phenobarbitone","author":"Rai","year":"1978"},{"key":"10.1016\/j.neurol.2011.02.035_bib0135","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1345\/aph.19242","article-title":"The role of carnitine supplementation during valproic acid therapy","volume":"34","author":"Raskind","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.neurol.2011.02.035_bib0140","first-page":"100","article-title":"Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs","volume":"22","author":"Ratnaike","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.neurol.2011.02.035_bib0145","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1021\/bi00024a013","article-title":"CYP 4\u00a0isoenzyme specificity and the relationship between om\u00e9ga-hydroxylation and terminal desaturation of valproic acid","volume":"34","author":"Rettie","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurol.2011.02.035_bib0150","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0013-7006(05)82378-4","article-title":"Troubles cognitifs, syndrome extrapyramidal et hyperammoni\u00e9mie sous traitement thymor\u00e9gulateur par divalproate de sodium: \u00e0 propos d\u2019un cas","volume":"31","author":"Ricard","year":"2005","journal-title":"Encephale"},{"key":"10.1016\/j.neurol.2011.02.035_bib0155","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0953-6205(03)00104-3","article-title":"A case of valproate-associated hepatotoxicity treated with L-carnitine","volume":"14","author":"Romero-Falc\u00f3n","year":"2003","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.neurol.2011.02.035_bib0160","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1528-1157.1979.tb04853.x","article-title":"Stupor following administration of valproic acid to patients receiving other antiepileptic drugs","volume":"20","author":"Sackellares","year":"1979","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2011.02.035_bib0165","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1528-1157.1988.tb03757.x","article-title":"Fatal liver failure in 16\u00a0children with valproate therapy","volume":"29","author":"Scheffner","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2011.02.035_bib0170","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1556\/ABiol.58.2007.4.11","article-title":"The effect of chronic diazepam administration on lipid peroxidation and Ca2+ -ATPase activity in rat liver","volume":"58","author":"Se\u00e7kin","year":"2007","journal-title":"Acta Biol Hung"},{"key":"10.1016\/j.neurol.2011.02.035_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00655.x","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"114","author":"Segura-Bruna","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2011.02.035_bib0180","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1081\/CLT-100102388","article-title":"Multicenter Case Series of Valproic acid Ingestion: Serum Concentrations and Toxicity","volume":"38","author":"Spiller","year":"2000","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.neurol.2011.02.035_bib0185","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00003088-199631030-00004","article-title":"Clinically significant pharmacokinetic drug interactions with carbamazepine. An update","volume":"31","author":"Spina","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.neurol.2011.02.035_bib0190","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5694\/j.1326-5377.2008.tb01780.x","article-title":"Hepatic encephalopathy precipitated by sodium valproate therapy","volume":"188","author":"Subhash","year":"2008","journal-title":"Med J Aust"},{"key":"10.1016\/j.neurol.2011.02.035_bib0195","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1528-1157.1983.tb03428.x","article-title":"Sodium valproate associated with phenobarbital: effects on ammonia metabolism in humans","volume":"24","author":"Warter","year":"1983","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.neurol.2011.02.035_bib0200","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0735-6757(03)00088-3","article-title":"2002\u00a0annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System","volume":"21","author":"Watson","year":"2003","journal-title":"Am J Emerg Med"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378711001202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378711001202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T04:02:53Z","timestamp":1741147373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378711001202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":39,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0035378711001202"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2011.02.035","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}